Trial intelligence / Profile preview

Delayed-release prednisone vs immediate-release prednisolone in newly diagnosed giant cell arteritis

2011-005090-22Phase 2Unknown

Sponsor
Southend University Hospital
Start
Jan 2012
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in giant cell arteritis (GCA) comparing Delayed-release Lodotra with Immediate-release prednisolone (2 arms). Primary endpoint: Persistent disease control and flare-free status at 26 weeks. Status: unknown.

02

Drugs

prednisoneprednisolone
03

Conditions

giant cell arteritis (GCA)

Beyond the preview

Go deeper on 2011-005090-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-005090-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call